BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 18065727)

  • 1. Optimal management of retroperitoneal metastatic nonseminomatous testicular cancer: toward a better selection between scalpel and needle.
    de Wit R
    J Clin Oncol; 2007 Dec; 25(35):5550-2. PubMed ID: 18065727
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
    J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
    Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
    BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of retroperitoneal lymph nodes in patients with locoregional nonseminomatous germ cell tumors: surveillance and primary chemotherapy.
    von Eschenbach AC; Swanson DA; Johnson DE; Wishnow KI; Stephenson RA; Babaian RJ
    Prog Clin Biol Res; 1991; 370():385-92. PubMed ID: 1718009
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of treatment of non-seminomatous tumours of the testis in pathological stage I.
    Wobbes T; Schraffordt Koops H; Oldhoff J; Sleijfer DT; Oosterhuis JW
    Neth J Surg; 1983 Jul; 35(3):89-93. PubMed ID: 6310445
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relapses of malignant nonseminomatous germinal testicular tumors].
    Piot G; Droz JP; Caillaud JM; Bellet D; Wibault P; Brulé G; Amiel JL
    J Urol (Paris); 1983; 89(1):49-51. PubMed ID: 6302168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of patients with retroperitoneal metastases of nonseminoma tumors of the testis].
    Matveev BP; Figurin KM
    Vopr Onkol; 1988; 34(12):1493-7. PubMed ID: 2464238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for clinical stage I nonseminomatous germ cell tumours.
    Vaughn DJ
    BJU Int; 2009 Nov; 104(9 Pt B):1381-6. PubMed ID: 19840017
    [No Abstract]   [Full Text] [Related]  

  • 9. Vox populi: Using community-based studies to determine best management of early-stage nonseminoma.
    Nichols CR; Kollmannsberger C
    J Clin Oncol; 2009 May; 27(13):2114-6. PubMed ID: 19307494
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
    Taue R; Harada A; Katto K; Yamamoto Y; Kishimoto T; Nakatuji Y; Tanimoto S; Oka N; Izaki H; Fukumori T; Takahashi M; Nishitani M; Kanayama HO
    Hinyokika Kiyo; 2006 Apr; 52(4):293-6. PubMed ID: 16686359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unusual development of nonseminomatous germ cell tumors of the testis (NSGCT)].
    Caty A; Depadt G; Feutry ML
    Bull Cancer; 1997 Aug; 84(8):796-9. PubMed ID: 9339184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of clinical stage I nonseminomatous germ cell testicular cancer.
    Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
    Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
    Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging and prognostic factors in nonseminomatous testicular cancer.
    Murphy P; Johnson DH
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1233-43. PubMed ID: 1663942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of retroperitoneal lymph node metastases in patients with non-seminomatous testicular cancer in clinical stage I.
    FossÄ SD; Ous S; Stenwig AE; Lien HH; Aass N; Kaalhus O
    Eur Urol; 1990; 17(2):107-12. PubMed ID: 2155789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance in stage I nonseminomatous germ cell tumours of the testis.
    Zuniga A; Kakiashvili D; Jewett MA
    BJU Int; 2009 Nov; 104(9 Pt B):1351-6. PubMed ID: 19840012
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonoperative approach for the management of clinical stage A nonseminomatous germ cell tumors.
    Jewett MA
    Semin Urol; 1984 Nov; 2(4):204-7. PubMed ID: 6095394
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Fornara P; Hoda MR
    Eur Urol; 2008 Nov; 54(5):1015-6. PubMed ID: 18722706
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Pizzocaro G
    Eur Urol; 2008 Nov; 54(5):1017-8. PubMed ID: 18722705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.